BRPI0700832A - composição anestésica nanoparticulada para uso tópico - Google Patents

composição anestésica nanoparticulada para uso tópico

Info

Publication number
BRPI0700832A
BRPI0700832A BRPI0700832-5A BRPI0700832A BRPI0700832A BR PI0700832 A BRPI0700832 A BR PI0700832A BR PI0700832 A BRPI0700832 A BR PI0700832A BR PI0700832 A BRPI0700832 A BR PI0700832A
Authority
BR
Brazil
Prior art keywords
nanoparticulate
topical use
anesthetic composition
anesthetic
composition
Prior art date
Application number
BRPI0700832-5A
Other languages
English (en)
Inventor
Dante Alario Jr
Guterres Silvia Staniscuaski
Pohlmann Adriana Raffin
Lali Ronsoni Zancan
Original Assignee
Biolab Sanus Farmaceutica Ltda
Univ Fed Do Rio Grande Do Sul
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39765309&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0700832(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biolab Sanus Farmaceutica Ltda, Univ Fed Do Rio Grande Do Sul filed Critical Biolab Sanus Farmaceutica Ltda
Priority to BRPI0700832A priority Critical patent/BRPI0700832B8/pt
Priority to US12/531,404 priority patent/US8568788B2/en
Priority to JP2009553872A priority patent/JP5496684B2/ja
Priority to EP08714517.3A priority patent/EP2134334B1/en
Priority to ES08714517T priority patent/ES2804466T3/es
Priority to CL200800728A priority patent/CL2008000728A1/es
Priority to HUE08714517A priority patent/HUE051155T2/hu
Priority to MX2009009853A priority patent/MX2009009853A/es
Priority to PL08714517T priority patent/PL2134334T3/pl
Priority to PT87145173T priority patent/PT2134334T/pt
Priority to PCT/BR2008/000070 priority patent/WO2008113144A1/en
Priority to ARP080101035A priority patent/AR065723A1/es
Priority to PE2008000474A priority patent/PE20081883A1/es
Priority to PE2013000512A priority patent/PE20131337A1/es
Publication of BRPI0700832A publication Critical patent/BRPI0700832A/pt
Priority to EC2009009691A priority patent/ECSP099691A/es
Priority to CO09114245A priority patent/CO6220944A2/es
Publication of BRPI0700832B1 publication Critical patent/BRPI0700832B1/pt
Publication of BRPI0700832B8 publication Critical patent/BRPI0700832B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPOSIçãO ANESTéSICA NANOPARTICULADA PARA USO TóPICO. A presente invenção se refere a uma composição anestésica nanoparticulada para uso tópico em que pelo menos um agente anestésico local está encapsulado em nanopartículas poliméricas. A presente invenção também se refere ao uso de tais nanopartículas políméricas compreendendo pelo menos um agente anestésico local, na preparação de uma composição anestésica para aplicação tópica sobre a pele ou mucosas.
BRPI0700832A 2007-03-16 2007-03-16 composição anestésica tópica compreendendo suspensão de nanocápsulas poliméricas de lidocaína e prilocaína BRPI0700832B8 (pt)

Priority Applications (16)

Application Number Priority Date Filing Date Title
BRPI0700832A BRPI0700832B8 (pt) 2007-03-16 2007-03-16 composição anestésica tópica compreendendo suspensão de nanocápsulas poliméricas de lidocaína e prilocaína
JP2009553872A JP5496684B2 (ja) 2007-03-16 2008-03-12 局所使用のためのナノ粒子状麻酔薬組成物
PL08714517T PL2134334T3 (pl) 2007-03-16 2008-03-12 Kompozycja znieczulająca w postaci nanocząstek do miejscowego stosowania
PCT/BR2008/000070 WO2008113144A1 (en) 2007-03-16 2008-03-12 Nanoparticulated anesthetic composition for topic use
EP08714517.3A EP2134334B1 (en) 2007-03-16 2008-03-12 Nanoparticulated anesthetic composition for topic use
ES08714517T ES2804466T3 (es) 2007-03-16 2008-03-12 Composición anestésica de uso tópico en forma de nanopartículas
CL200800728A CL2008000728A1 (es) 2007-03-16 2008-03-12 Composicion anestesica para la administracion topica que comprende un agente anestesico local en nanoparticulas polimericas y por lo menos un agente que aumenta la viscosidad.
HUE08714517A HUE051155T2 (hu) 2007-03-16 2008-03-12 Nanorészecske formájú fájdalomcsillapító készítmény topikális alkalmazásra
MX2009009853A MX2009009853A (es) 2007-03-16 2008-03-12 Composicion anestesica nanoparticulada para la administracion topica.
US12/531,404 US8568788B2 (en) 2007-03-16 2008-03-12 Nanoparticulated anesthetic composition for topic use
PT87145173T PT2134334T (pt) 2007-03-16 2008-03-12 Composição anestésica nanoparticulada para utilização tópica
ARP080101035A AR065723A1 (es) 2007-03-16 2008-03-13 Composicion anestesica nanoparticulada para la administracion topica
PE2013000512A PE20131337A1 (es) 2007-03-16 2008-03-13 Composicion anestesica nanoparticulada para la administracion topica
PE2008000474A PE20081883A1 (es) 2007-03-16 2008-03-13 Composicion anestesica nanoparticulada para la administracion topica
EC2009009691A ECSP099691A (es) 2007-03-16 2009-10-14 Composición anestésica nanoparticulada para la administración tópica
CO09114245A CO6220944A2 (es) 2007-03-16 2009-10-14 Composicion anestesica nanoparticulada para la administracion topica

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0700832A BRPI0700832B8 (pt) 2007-03-16 2007-03-16 composição anestésica tópica compreendendo suspensão de nanocápsulas poliméricas de lidocaína e prilocaína

Publications (3)

Publication Number Publication Date
BRPI0700832A true BRPI0700832A (pt) 2008-11-04
BRPI0700832B1 BRPI0700832B1 (pt) 2017-12-26
BRPI0700832B8 BRPI0700832B8 (pt) 2021-05-25

Family

ID=39765309

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0700832A BRPI0700832B8 (pt) 2007-03-16 2007-03-16 composição anestésica tópica compreendendo suspensão de nanocápsulas poliméricas de lidocaína e prilocaína

Country Status (15)

Country Link
US (1) US8568788B2 (pt)
EP (1) EP2134334B1 (pt)
JP (1) JP5496684B2 (pt)
AR (1) AR065723A1 (pt)
BR (1) BRPI0700832B8 (pt)
CL (1) CL2008000728A1 (pt)
CO (1) CO6220944A2 (pt)
EC (1) ECSP099691A (pt)
ES (1) ES2804466T3 (pt)
HU (1) HUE051155T2 (pt)
MX (1) MX2009009853A (pt)
PE (2) PE20081883A1 (pt)
PL (1) PL2134334T3 (pt)
PT (1) PT2134334T (pt)
WO (1) WO2008113144A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2738524C (en) 2008-10-02 2013-11-26 Mylan Inc. Method for making a multilayer adhesive laminate
BR102012022036B1 (pt) * 2012-08-31 2019-10-01 Biolab Sanus Farmacêutica Ltda. Nanopartícula polimérica de finasterida e minoxidil, processo de sua preparação, suspensão aquosa contendo a mesma, composição farmacêutica, e seu uso
BR102014028009B1 (pt) 2014-11-10 2023-04-18 Universidade Federal De Pelotas Composições filmogênicas para bioadesivos anestésicos tópicos (bats) para liberação controlada de princípios ativos e bioadesivos anestésicos tópicos
US11452700B2 (en) 2017-08-04 2022-09-27 Eric Haas Method of delivering an anesthetic agent and glucocorticoid micro and nano bioerodible particles
CN113244167B (zh) * 2021-05-20 2022-11-29 河北科技大学 一种盐酸利多卡因凝胶及其制备方法
RU208882U1 (ru) * 2021-08-25 2022-01-19 Федеральное государственное бюджетное образовательное учреждение высшего образования "Курская государственная сельскохозяйственная академия имени И.И. Иванова" Раневая атравматическая повязка для животных

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7713618L (sv) * 1977-12-01 1979-06-02 Astra Laekemedel Ab Lokalanestetisk blandning
FR2659554B1 (fr) * 1990-03-16 1994-09-30 Oreal Composition pour le traitement cosmetique et/ou pharmaceutique des couches superieures de l'epiderme par application topique sur la peau et procede de preparation correspondant.
DE4120760A1 (de) * 1991-06-24 1993-03-04 3 M Medica Gmbh Traegersysteme fuer arzneimittel
JPH09255565A (ja) * 1996-03-26 1997-09-30 Daikyo Yakuhin Kogyo Kk 皮膚局所麻酔用ヒドロゲルパッチ
BR9815499A (pt) * 1997-07-02 2001-01-02 Euro Celtique Sa Anestesia prolongada nas juntas e nos espacos corporais.
US5993836A (en) * 1998-04-28 1999-11-30 Castillo; James G. Topical anesthetic formulation
KR100463167B1 (ko) * 2001-04-13 2004-12-23 주식회사 태평양 고분자 나노입자를 이용한 경피흡수제 및 이를 함유한외용제 조성물
US20070154527A1 (en) * 2001-10-12 2007-07-05 Monosoirx, Llc Topical film compositions for delivery of actives
US20080124400A1 (en) * 2004-06-24 2008-05-29 Angiotech International Ag Microparticles With High Loadings Of A Bioactive Agent
US8940311B2 (en) * 2004-10-21 2015-01-27 Tae-Hong Lim In situ controlled release drug delivery system
WO2006091719A2 (en) * 2005-02-23 2006-08-31 Sontra Medical Corporation Compositions and methods enhancing transdermal delivery of drugs and biologics

Also Published As

Publication number Publication date
HUE051155T2 (hu) 2021-03-01
BRPI0700832B1 (pt) 2017-12-26
CL2008000728A1 (es) 2008-09-26
US20100086614A1 (en) 2010-04-08
BRPI0700832B8 (pt) 2021-05-25
PE20081883A1 (es) 2008-12-27
EP2134334A4 (en) 2013-04-24
EP2134334B1 (en) 2020-05-13
AR065723A1 (es) 2009-06-24
JP2010521498A (ja) 2010-06-24
MX2009009853A (es) 2010-02-18
PL2134334T3 (pl) 2021-03-08
ES2804466T3 (es) 2021-02-08
PE20131337A1 (es) 2013-11-18
ECSP099691A (es) 2010-02-26
EP2134334A1 (en) 2009-12-23
PT2134334T (pt) 2020-08-20
CO6220944A2 (es) 2010-11-19
US8568788B2 (en) 2013-10-29
JP5496684B2 (ja) 2014-05-21
WO2008113144A1 (en) 2008-09-25

Similar Documents

Publication Publication Date Title
BRPI0700832A (pt) composição anestésica nanoparticulada para uso tópico
BRPI0921002A8 (pt) Composições para tratamento bucal compreendendo sílica fundida e seu uso
BRPI0910874B8 (pt) formulação tópica para uso no tratamento tópico de uma condição da pele que resulta da produção de espécies reativas de oxigênio e/ou para a promoção da cicatrização de ferida tópica na pele de um indivíduo e uso da referida formulação
BR112015019657A2 (pt) composições tópicas e métodos de uso das mesmas
CL2008000893A1 (es) Composición para el cuidado bucal que comprende una cantidad efectiva de un aminoácido básico y un agente antibacteriano; uso en el tratamiento antibacteriano de la cavidad bucal.
BRPI1103213B8 (pt) Composição de enxaguatório bucal antimicrobiano com teor alcoólico reduzido à base de óleo essencial bioativo
UY31765A (es) Dihidropirazolonas sustituidas y su uso
BR112016013195A2 (pt) Composições para a higiene bucal compreendendo carbonato de cálcio e uma argila
BR112014030962A2 (pt) métodos para preparação e para reconstituição de uma composição seca adequada para uso em hemostase e cicatrização de feridas, e, kit hemostático
BR112015016082A2 (pt) curativo indicador de umidade
UY30663A1 (es) Dihidropirazolonas sustituidas y su uso
AR077199A1 (es) Composicion farmaceutica y procedimiento de tratamiento para la anticoncepcion de emergencia
BR112015027704A2 (pt) Composto, uso do mesmo e composição farmacêutica antibacteriana
BRPI0907871A2 (pt) Artigo absorvente que compreende composição de loção que compreende um agente de resfriamento
BR112016014271A2 (pt) composições tópicas em gel incluindo polímero de poli(monoestearoil glicerol-co-succi¬nato) e métodos para aprimorar a aplicação tópica de um agente de benefício
ES2980898T3 (es) Composición de estimulación del crecimiento de células epiteliales
BR112012023942A2 (pt) curativo para feridas e processo para a preparação de um curativo para feridas.
CR20130684A (es) Composición limpiadora que comprende un agente gelificante y un tensioactivo empumante
BR112015010392A2 (pt) composição para tratamento de pele
BR112012011282A2 (pt) material à base de gesso incluindo um agente capaz de reter formaldeído
BR112013004455A2 (pt) composições para fornecimento gástrico de agentes ativos
CL2009000665A1 (es) Compuestos derivados de pirrolidinilo; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la ansiedad, depresion o ambas.
BR112012027393A2 (pt) composto da fórmula geral i, composição farmacêutica, uso de um composto e método de tratamento de qualquer mamífero, notadamente um humano, afetado por câncer
BR112014002060A2 (pt) composições para uso na seção úmida da fabricação de papel
BR112014018138A8 (pt) Composição de tratamento de superfície, meio de impressão e método para preparar uma composição de tratamento de superfície utilizada na fabricação de papel

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B65X Notification of requirement for priority examination of patent application
B65Y Grant of priority examination of the patent application (request complies with dec. 132/06 of 20061117)
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 26/12/2017, OBSERVADAS AS CONDICOES LEGAIS.

B15K Others concerning applications: alteration of classification

Ipc: A61K 9/51 (2006.01), A61P 23/02 (2006.01)

B16C Correction of notification of the grant

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/03/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF